These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10866472)

  • 1. Growth-hormone treatment and risk of diabetes.
    Spyer G; Ellard S; Hattersley A
    Lancet; 2000 May; 355(9218):1913-4. PubMed ID: 10866472
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth-hormone treatment and risk of diabetes.
    Fukui M; Nakamura N; Kondo M
    Lancet; 2000 May; 355(9218):1912-3; author reply 1913-4. PubMed ID: 10866470
    [No Abstract]   [Full Text] [Related]  

  • 3. Can growth hormone therapy cause diabetes?
    Jeffcoate W
    Lancet; 2000 Feb; 355(9204):589-90. PubMed ID: 10696973
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.
    Cutfield WS; Wilton P; Bennmarker H; Albertsson-Wikland K; Chatelain P; Ranke MB; Price DA
    Lancet; 2000 Feb; 355(9204):610-3. PubMed ID: 10696981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of insulin resistance in IGT].
    Asakawa H; Tokunaga K
    Nihon Rinsho; 1997 Nov; 55 Suppl():822-6. PubMed ID: 9434571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glucose intolerance with antipsychotic drugs].
    Naitoh H; Manabe Y; Iwata N
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():329-32. PubMed ID: 15779397
    [No Abstract]   [Full Text] [Related]  

  • 7. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany.
    Wabitsch M; Hauner H; Hertrampf M; Muche R; Hay B; Mayer H; Kratzer W; Debatin KM; Heinze E
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):307-13. PubMed ID: 14724655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between interferon therapy and glucose tolerance].
    Uehara S; Honjo K; Handa H; Hirayama A
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():661-5. PubMed ID: 9513494
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin-like growth factor I and impaired glucose tolerance.
    Dunger D; Yuen K; Ong K
    Horm Res; 2004; 62 Suppl 1():101-7. PubMed ID: 15761241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment and type 2 diabetes.
    Kohno H; Kuromaru R; Ueyama N; Miyako K
    Growth Horm IGF Res; 2001 Jun; 11(3):196-7. PubMed ID: 11735234
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment.
    Groop L; Segerlantz M; Bramnert M
    Horm Res; 2005; 64 Suppl 3():45-50. PubMed ID: 16439844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-insulin dependent diabetes mellitus: a phenomenon of ageing?
    Heine RJ
    Int J Epidemiol; 1991; 20 Suppl 1():S18-24. PubMed ID: 9119543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both].
    Starzyk J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):79-84. PubMed ID: 15996336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From the natural history of non-insulin-dependent diabetes and its etiopathogenesis].
    Brogard JM; Robillart I
    Rev Med Interne; 1994; 15 Suppl 3():266S-269S. PubMed ID: 7863130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance to insulin and polycystic ovary syndrome].
    Ducluzeau PH; Laville M; Vidal H; Pugeat M
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S7-12. PubMed ID: 11787441
    [No Abstract]   [Full Text] [Related]  

  • 16. Childhood obesity and type 2 diabetes mellitus.
    Hannon TS; Rao G; Arslanian SA
    Pediatrics; 2005 Aug; 116(2):473-80. PubMed ID: 16061606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus.
    Chiu KC; McCarthy JE
    Biochem Biophys Res Commun; 1996 Apr; 221(3):614-8. PubMed ID: 8630009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANP-ing Up Diabetes: Impaired Natriuretic Peptide Action in Muscle Forms a Mechanistic Link Between Obesity and Diabetes.
    Cleasby ME
    Diabetes; 2015 Dec; 64(12):3978-80. PubMed ID: 26604170
    [No Abstract]   [Full Text] [Related]  

  • 19. A defective beta-cell glucose sensor as a cause of diabetes.
    Weir GC
    N Engl J Med; 1993 Mar; 328(10):729-31. PubMed ID: 8433735
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heterogeneity in pathogenesis of NIDDM and recent advances in research of diabetogenic genes].
    Seino Y; Yamada Y
    Nihon Rinsho; 1994 Oct; 52(10):2686-92. PubMed ID: 7983798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.